Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer

World J Gastroenterol. 2017 Mar 14;23(10):1780-1786. doi: 10.3748/wjg.v23.i10.1780.

Abstract

Aim: To compare the expression levels of interleukin (IL)-6 in colorectal cancer (CRC) tissues and adjacent non-cancerous tissues, and analyse the correlation of IL-6 expression with the clinicopathological parameters of CRC.

Methods: Fifty CRC tissue specimens and 50 matched adjacent mucosa specimens were collected. The expression of IL-6 in these clinical samples was examined by immunohistochemical staining. The correlation between IL-6 expression and clinicopathological parameters was assessed by statistical analysis.

Results: IL-6 expression was significantly elevated in CRC tissues compared with noncancerous tissues (P < 0.001). IL-6 expression was positively correlated with tumour TNM stage (P < 0.001), but a negative correlation was detected between IL-6 expression and tumor histological differentiation in CRC (P < 0.05). Furthermore, IL-6 expression was associated with invasion depth and lymph node metastasis in CRC.

Conclusion: IL-6 might be a useful marker for predicting a poor prognosis in patients with CRC and might be used as a potential therapeutic target in CRC.

Keywords: Colorectal cancer; Interleukin-6; Invasion depth; Lymph node metastases.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / metabolism
  • Colorectal Neoplasms / metabolism*
  • Colorectal Neoplasms / pathology
  • Colorectal Neoplasms / surgery
  • Female
  • Humans
  • Immunohistochemistry
  • Interleukin-6 / metabolism*
  • Intestinal Mucosa / metabolism*
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Molecular Targeted Therapy / methods
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Prognosis

Substances

  • Biomarkers, Tumor
  • IL6 protein, human
  • Interleukin-6